Drug Profile
Research programme: calcitonin analogues - Nordic Bioscience
Alternative Names: UGP-302Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Unigene Laboratories
- Developer Nordic Bioscience; Unigene Laboratories
- Class Peptides
- Mechanism of Action Calcitonin receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Osteoarthritis; Osteoporosis; Type 2 diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Osteoarthritis in Denmark (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Osteoarthritis in USA (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Osteoporosis in Denmark (PO)